In the most recent trading session, Novavax (NVAX) closed at $8.45, indicating a +0.24% shift from the previous trading day.

The vote by the U.S. Senate Finance Committee paves the way for the full Senate to vote to confirm him as secretary of the ...

According to the 6 industry analysts covering Novavax, the consensus is that breakeven is near. They anticipate the company to incur a final loss in 2024, before generating positive profits of US$82m ...

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Robert F. Kennedy Jr., President Donald Trump’s pick to head the US Department of Health and Human Services, was endorsed by ...

The bitter legal battle continues, with Baldoni launching a new website including texts and documents he says back his defense against Lively's sexual harassment claims. Josh Peck's wife of seven ...

Shares of Novavax Inc. NVAX slipped 2.99% to $8.43 Monday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 1.20% to ...

The company announced that the Food and Drug Administration (FDA) has approved Journavx, a twice-daily pill that it described as a "highly selective NaV1.8 pain signal inhibitor for the treatment of ...

Novavax Inc. closed 62.24% below its 52-week high of $23.86, which the company reached on June 6th.

HWGAX’s 3-year and 5-year annualized returns are 7% and 9%, respectively. HWGAX has a Zacks Mutual Fund Rank #1. Its net expense ratio is 1.20%. Hotchkis & Wiley Small Cap Value Fund invests the ...